MedTrace Logo

Effects of Hemp-Derived Cannabinoids on Menopause Symptoms

NCT07393672 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2026-03-10

No results posted yet for this study

Summary

The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Conditions

Interventions

DRUG

Hemp-derived cannabinoids

Participants will be administered a legal product with hemp-derived cannabinoids and terpenes.

DRUG

Placebo

Participants will be administered a placebo

Sponsors & Collaborators

  • Terra Mater Botanicals Pty Ltd

    collaborator UNKNOWN

  • Washington State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-11
Primary Completion
2026-11-10
Completion
2026-11-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07393672 on ClinicalTrials.gov